News & Perspective

Dec 21, 2001

Dec 21, 2001

FDA completes inspection of anthrax vaccine plant; company expects approval

(CIDRAP News) – The Food and Drug Administration (FDA) has completed a new inspection of BioPort Corp., the only US manufacturer of the anthrax vaccine, and a company official is predicting approval of the facility after a few remaining concerns are ironed out.

Dec 19, 2001

Dec 19, 2001

Anthrax vaccine to be offered to postal and Capitol workers

(CIDRAP News) – Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.

Dec 13, 2001

Dec 13, 2001

Finding an antitoxin is among priorities for anthrax research

(CIDRAP News) – The Centers for Disease Control and Prevention's (CDC's) priorities for research on anthrax include development of an antitoxin, aerosolization of anthrax powders sent by mail, and postexposure prophylaxis, CDC officials said this week.

Dec 10, 2001

Dec 10, 2001

HHS announces new bioterrorism research initiatives

(CIDRAP News) – The US Department of Health and Human Services (HHS) has announced seven new research grant programs to speed efforts to prevent, diagnose, and treat diseases related to bioterrorism.

Dec 07, 2001

Dec 07, 2001

Rapid tests for environmental anthrax should not be used alone, CDC says

(CIDRAP News) – Rapid tests for detecting anthrax spores on surfaces should not be used alone as the basis for public health or clinical decisions, the Centers for Disease Control and Prevention warned in today's issue of Morbidity and Mortality Weekly Report.

Dec 06, 2001

Dec 06, 2001

85 million mail items processed at anthrax-contaminated facilities, CDC reports

(CIDRAP News) – Eighty-five million pieces of mail were processed at anthrax-contaminated Postal Service plants in New Jersey and Washington, DC, before the plants were closed, the Centers for Disease Control and Prevented (CDC) reported today. Although the numbers suggest that cross-contaminated mail may be widespread, officials said the risk of contracting inhalational anthrax from such mail is very low.

Dec 05, 2001

Dec 05, 2001

Quarantine not likely to be best tool for halting bioterrorism-related disease, experts say

(CIDRAP News) – Large-scale quarantine of potentially exposed people is not likely to be the optimal strategy for containing a disease outbreak resulting from bioterrorism in most circumstances, according to public health experts writing in today's issue of the Journal of the American Medical Association.

Nov 30, 2001

Nov 30, 2001

Ciprofloxacin side effects ranged up to 19% in postal workers

(CIDRAP News) – About 19% of more than 3,000 postal workers who took ciprofloxacin to prevent anthrax from the recent bioterrorist attacks reported having "severe" gastrointestinal side effects, but only 2% sought medical attention for them, according to the Centers for Disease Control and Prevention (CDC). Officials described the findings as being in line with other reports on ciprofloxacin.

Nov 22, 2001

Nov 22, 2001

Three deaths after knee surgery prompt CDC search for similar cases

Nov 21, 2001 (CIDRAP News)—A cluster of three unexplained deaths after routine knee surgeries in Minnesota has prompted the Centers for Disease Control and Prevention (CDC) to hunt for similar cases nationwide and caused Minnesota health officials to call a 1-week moratorium on elective knee surgeries.

Nov 21, 2001

Nov 21, 2001

Elderly Connecticut woman dies of inhalational anthrax from unknown source

(CIDRAP News) – The nation's fifth recent death due to inhalational anthrax—that of a 94-year-old Connecticut woman—was announced today as public health officials were explaining that they don't know how the patient contracted anthrax but don't think it was from a naturally occurring source.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»